Back to dashboard
Medicare AdvantagePrior AuthLow impact

Cardiac Hemodynamic Monitoring

Blue Cross Blue Shield of Rhode Island·RI · Cardiology, Critical Care·Physician / Facility
Effective date
Oct 1, 2019
We identified it
Jun 20, 2026
Days to comply

Summary

Effective October 1, 2019, cardiac hemodynamic monitoring using thoracic electrical bioimpedance no longer requires prior authorization for BlueCHiP Medicare patients. Commercial coverage and other monitoring methods remain unchanged.

Action Required

Action needed
No immediate action required as this is an older policy (October 2019) that should already be implemented. Verify billing system is configured to NOT require prior authorization for thoracic electrical bioimpedance cardiac monitoring for BlueCHiP Medicare patients.